phase readout
saveNCT07526961: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Non-Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that